The safety of Panchakarma (~five internal bio-cleansing therapies) protocol, including Purvakarma (~preparatory procedures) such as Snehapana (~internal oleation) and Swedana (~therapeutic sudation), varies significantly depending on the quality of drugs used and the patient’s comorbidities. Snehapana , the oleation therapy, indeed has a significant impact on lipid metabolism. Research suggests that derangements in the complicated dynamics of lipid metabolism have a significant impact on cardiovascular well-being. This is a case report of a 45-year-old male diagnosed with avascular necrosis (Stage III) of bilateral femoral head with a previous history of coronary artery disease, who developed an episode of acute cardiac syndrome after undergoing Snehapana , Swedana, and Virechana (~therapeutic purgation). Subsequently, he was referred to a higher center and was managed successfully. The case report highlights the importance of determining the Paka (~transformation) of Taila (~oil) for Snehapana , particularly in high-risk groups, investigating potential interactions with concomitant allopathic medications, and establishing safe dosage ranges while practicing Shodhananga snehapana (~internal oleation for purification). Proper surveillance of the source of formulations used and their quality assurance is indispensable to minimize safety concerns in vulnerable groups undergoing Panchakarma procedures.
P. P. Pradeepkumar (Wed,) studied this question.